Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, showed up to 24% weight loss in phase 2 trials
GLP-1RAs
Preparation of semaglutide long-acting injectable microcapsules with physicochemical properties, long-term stability, and pharmacokinetics and pharmacodynamics
If a needle-free format matters to you, PlexusDx offers Semaglutide Oral and the Microdose GLP-1 Protocol with four delivery variants, but injection remains the most evidence-supported delivery format for weight loss
It helps regulate blood glucose by enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and promoting satiety
Are using tirzepatide and concerned about regulatory risk